Cargando…

Serum YKL-40 Levels Correlate with Infarct Volume, Stroke Severity, and Functional Outcome in Acute Ischemic Stroke Patients

BACKGROUND AND PURPOSE: YKL-40 is associated with various neurological disorders. However, circulatory YKL-40 levels early after onset of acute ischemic stroke (AIS) have not been systematically assessed. We aimed to identify the temporal changes and clinical usefulness of measuring serum YKL-40 imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hyun Young, Jun, Chang-Duk, Jeon, Se-Jeong, Choi, See-Sung, Kim, Hak-Ryul, Choi, Dan-Bee, Kwak, Seongae, Lee, Hak-Seung, Cheong, Jin Sung, So, Hong-Seob, Lee, Young-Jin, Park, Do-Sim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522716/ https://www.ncbi.nlm.nih.gov/pubmed/23272150 http://dx.doi.org/10.1371/journal.pone.0051722

Ejemplares similares

Association between Elevated Pleural Interleukin-33 Levels and Tuberculous Pleurisy
por: Lee, Koung-Sun, et al.
Publicado: (2013)

The role of YKL-40 in the pathogenesis of autoimmune diseases: a comprehensive review
por: Tizaoui, Kalthoum, et al.
Publicado: (2022)

The Relationship Between Serum YKL-40 Levels on Admission and Stroke-Associated Pneumonia in Patients with Acute Ischemic Stroke
por: Shi, Guomei, et al.
Publicado: (2021)

Serum YKL-40 Levels and White Matter Hyperintensities in Patients with Acute Ischemic Stroke
por: Shi, Guomei, et al.
Publicado: (2023)

Independent Predictive Value of Elevated YKL-40 in Ischemic Stroke Prognosis: Findings from a Nationwide Stroke Registry
por: Qin, Haiqiang, et al.
Publicado: (2023)

Prognostic performance of serum YKL-40 for one-year clinical outcomes in acute ischemic stroke
por: Shi, Guomei, et al.
Publicado: (2023)

Deep Learning-Based Stroke Disease Prediction System Using Real-Time Bio Signals
por: Choi, Yoon-A, et al.
Publicado: (2021)

Serum YKL-40 levels may help distinguish exacerbation of post-infectious bronchiolitis obliterans from acute bronchiolitis in young children
por: Jang, Yoon Young, et al.
Publicado: (2017)

Serum YKL-40 Levels Are Associated with the Atherogenic Index of Plasma in Children
por: Kwon, Yoowon, et al.
Publicado: (2020)

Serum YKL-40 and colorectal cancer
por: Cintin, C, et al.
Publicado: (1999)

YKL-40 correlates with the phenotype of asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Causal Effects of YKL‐40 on Ischemic Stroke and Its Subtypes: A 2‐Sample Mendelian Randomization Study
por: Xu, Qingyun, et al.
Publicado: (2023)

Systemic Immune Modulation in Gliomas: Prognostic Value of Plasma IL-6, YKL-40, and Genetic Variation in YKL-40
por: Holst, Camilla Bjørnbak, et al.
Publicado: (2020)

Tooth Loss May Predict Poor Cognitive Function in Community-Dwelling Adults without Dementia or Stroke: The PRESENT Project
por: Park, Hyunyoung, et al.
Publicado: (2013)

Selection and Characterization of YKL-40-Targeting Monoclonal Antibodies from Human Synthetic Fab Phage Display Libraries
por: Kang, Kyungjae, et al.
Publicado: (2020)

Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study
por: Li, Jiejie, et al.
Publicado: (2022)

YKL-40 Protein Correlates with the Phenotype of Asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2015)

Plasma YKL-40 in the spectrum of neurodegenerative dementia
por: Villar-Piqué, Anna, et al.
Publicado: (2019)

Acute Ischemic Stroke in a Patient with a Native Valvular Strand
por: Rhee, Hak Young, et al.
Publicado: (2010)

Expression Profile of Three Splicing Factors in Pleural Cells Based on the Underlying Etiology and Its Clinical Values in Patients with Pleural Effusion
por: Han, A-Lum, et al.
Publicado: (2017)

Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus
por: Kim, Hyun Min, et al.
Publicado: (2012)

Variations of CHI3L1, Levels of the Encoded Glycoprotein YKL-40 and Prediction of Fatal and Non-fatal Ischemic Stroke
por: Rathcke, Camilla Noelle, et al.
Publicado: (2012)

Fenofibrate exerts protective effects against gentamicin-induced toxicity in cochlear hair cells by activating antioxidant enzymes
por: Park, Channy, et al.
Publicado: (2017)

YKL-40 - an emerging biomarker in cardiovascular disease and diabetes
por: Rathcke, Camilla N, et al.
Publicado: (2009)

Serum YKL-40 Levels in Patients with Gastric Cancer
por: Itik, Veyis, et al.
Publicado: (2011)

YKL-40 in the brain and cerebrospinal fluid of neurodegenerative dementias
por: Llorens, Franc, et al.
Publicado: (2017)

YKL-40 as a possible marker of neutrophilic asthma
por: Specjalski, Krzysztof, et al.
Publicado: (2023)

YKL-40 and the Cellular Metabolic Profile in Parkinson’s Disease
por: Gevezova, Maria, et al.
Publicado: (2023)

Association of Aortic Knob Calcification with Intracranial Stenosis in Ischemic Stroke Patients
por: Kim, Young Seo, et al.
Publicado: (2013)

Prognostic Significance of Prolonged Corrected QT Interval in Acute Ischemic Stroke
por: Ahn, Sung-Ho, et al.
Publicado: (2021)

YKL-40 is a Protective Biomarker for Fatty Liver in World Trade Center Particulate Matter-Exposed Firefighters
por: Cho, Soo Jung, et al.
Publicado: (2014)

Role of breast regression protein-39/YKL-40 in asthma and allergic responses
por: Lee, Chun Geun, et al.
Publicado: (2010)

Prospects of Therapeutic Target and Directions for Ischemic Stroke
por: Kim, Jung Hak, et al.
Publicado: (2021)

Urinary YKL-40 as a Candidate Biomarker for Febrile Urinary Tract Infection in Young Children
por: Kim, Hyun Hee, et al.
Publicado: (2018)

Significance of Vertigo, Imbalance, and Other Minor Symptoms in Hyperacute Treatment of Posterior Circulation Stroke
por: Kim, Min, et al.
Publicado: (2022)

Explanatory Power and Prognostic Implications of Factors Associated with Troponin Elevation in Acute Ischemic Stroke
por: Ahn, Sung-Ho, et al.
Publicado: (2023)

YKL-40, a secreted glycoprotein, promotes tumor angiogenesis
por: Shao, Rong, et al.
Publicado: (2009)

YKL-40 acts as an angiogenic factor to promote tumor angiogenesis
por: Shao, Rong
Publicado: (2013)

Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization
por: Shao, Rong, et al.
Publicado: (2015)

Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
por: Janelidze, Shorena, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kkv96vfhmjnijtr0pmn4holoe5